Trial Profile
Two and Three Dimensional Contrast-Enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2019
Price :
$35
*
At a glance
- Drugs Perflutren (Primary)
- Indications Renal cell carcinoma
- Focus Diagnostic use
- 10 Apr 2019 Status changed from recruiting to completed.
- 14 May 2015 New trial record